Hypothalamus-Pituitary-Adrenal Axis Hypersuppression Is Associated with Gastrointestinal Symptoms in Major Depression = Hypothalamus-Pituitary-Adrenal Axis Hypersuppression Is Associated with Gastrointestinal Symptoms in Major Depression

다국어 초록 (Multilingual Abstract)

Background/Aims Gastrointestinal symptoms and hypothalamus-pituitary-adrenal (HPA) axis dysfunction are frequently observed in patients with major depression. The primary aim of the study was to investigate the relationship between HPA-axis function and self-perceived functional gastrointestinal symptoms in major depression. Methods Patients with major depression (n = 73) and controls representative of the general population (n = 146) underwent a weightadjusted very low dose dexamethasone suppression test (DST). Patients and controls completed the gastrointestinal symptom rating scale-iritable bowel syndrome (GSRS-IBS) and the hospital anxiety depression scale. Medical records of the patients were screened over a ten year period for functional gastrointestinal disorder and pain conditions. Results Patients with high GSRS-IBS scores (above median) exhibited HPA-axis hypersuppression more often than controls (defined by the lowest 10% cutoff of the post-DST cortisol values among controls, adjusted OR 7.25, CI 1.97-26.7) whereas patients with low GSRS-IBS scores did not differ from controls concerning their post-DST cortisol values. Patients who had consulted primary care for functional gastrointestinal disorder (P = 0.039), lumbago (P = 0.006) and chronic multifocal pain (P = 0.057) also exhibited an increased frequency of hypersuppression. Conclusions HPA-axis hypersuppression is associated with functional gastrointestinal symptoms in patients with major depression. (J Neurogastroenterol Motil 2016;22:292-303)

참고문헌 (Reference)

• 1 Oldehinkel AJ, "Urinary free cortisol excretion in elderly persons with minor and major depression" 104 : 39-47, 2001
• 2 Stahl S, "Understanding pain in depression" 19 (19): S9-S13, 2004
• 3 Rask E, "Tissue-specific dysregulation of cortisol metabolism in human obesity" 86 : 1418-1421, 2001
• 4 Bjelland I, "The validity of the hospital anxiety and depression scale. An update literature review" 52 : 69-77, 2002
• 5 Heim C, "The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders" 25 : 1-35, 2000
• 6 Cleare AJ, "The neuroendocrinology of chronic fatigue syndrome" 24 : 236-252, 2003
• 7 Mayer EA, "The neurobiology of stress and gastrointestinal disease" 47 : 861-869, 2000
• 8 Wingenfeld K, "The low-dose dexamethasone suppression test in fibromyalgia" 62 : 85-91, 2007
• 9 Veen G, "The influence of psychiatric comorbidity on the dexamethason/CRH test in major depression" 19 : 409-415, 2009
• 10 Zigmond AS, "The hospital nxiety and depression scale" 67 : 361-370, 1983
• 11 Carroll BJ, "The dexamethasone suppression test for melancholia" 140 : 292-304, 1982
• 12 Holsboer F, "The corticosteroid receptor hypothesis of depression" 23 : 477-501, 2000
• 13 Nilsson LG, "The Betula prospective cohort study: memory, health, and aging" 4 : 1-32, 1997
• 14 Kendler KS, "Stressful life events, genetic liability, and onset of major depression in women" 152 : 833-842, 1995
• 15 Yehuda R, "Status of glucocorticoid alterations in post-traumatic stress disorder" 1179 : 56-69, 2009
• 16 Karling P, "Spectral analysis of heart rate variability in patients with irritable bowel syndrome" 33 : 572-576, 1998
• 17 Wikgren M, "Short telomeres in depression and the general population are associated with a hypocortisolemic state" 71 : 294-300, 2012
• 18 Roberts AD, "Salivary cortisol response to awakening in chronic fatigue syndrome" 184 : 136-141, 2004
• 19 Sudhaus S, "Salivary cortisol and psychological mechanisms in patients with acute versus chronic low back pain" 34 : 513-522, 2009
• 20 Maripuu M, "Relative hypo- and hypercortisolism are both associated with depression and lower quality of life in bipolar disorder: a cross-sectional study" 9 : e98682-, 2014
• 21 Keller MB, "Relapse in major depressive disorder: analysis with life table" 39 : 911-915, 1982
• 22 Gaab J, "Reduced reactivity and enhanced negative feedback sensitivity of the hypothalamus-pituitary-adreanal axis in chronic whiplash-associated disorder" 119 : 219-224, 2005
• 23 Dimenäs E, "Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens?" 28 : 681-687, 1993
• 24 Justin CY Wu, "Psychological Co-morbidity in Functional Gastrointestinal Disorders: Epidemiology, Mechanisms and Management" 대한소화기 기능성질환∙운동학회 18 (18): 13-18, 2012
• 25 Zhou L, "Psychobiotics and the gut-brain axis: in pursuit of happiness" 16 : 715-723, 2015
• 26 Corruble E, "Pain complaints in depressed inpatients" 33 : 307-309, 2000
• 27 Gold PW, "Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states" 7 : 254-275, 2002
• 28 Salehi M, "Obesity and cortisol status" 37 : 193-197, 2005
• 29 Karling P, "No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission" 19 : 896-904, 2007
• 30 Rydmark I, "Neuroendocrine, cognitive and structural imaging characteristics of women on longterm sickleave with job stress-induced depression" 60 : 867-873, 2006
• 31 Maletic V, "Neurobiology of depression, fibromyalgia and neuropathic pain" 14 : 5291-5338, 2009
• 32 Bremmer MA, "Major depression in late life is associated with both hypo- and hypercortisolemia" 62 : 479-486, 2007
• 33 Masand P, "Major depression and irritable bowel syndrome: is there a relationship?" 56 : 363-367, 1995
• 34 Penninx BW, "Late-life depressive symptoms are associated with both hyperactivity and hypoactivity of the hypothalamo-pituitary-adrenal axis" 15 : 522-529, 2007
• 35 Törnblom H, "Inflammation as a cause of functional bowel disorders" 40 : 1140-1148, 2005
• 36 Fukudo S, "Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and in patients with irritable bowel syndrome" 42 : 845-849, 1998
• 37 Miller GE, "If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans" 133 : 25-45, 2007
• 38 Dinan TG, "Hypothalamic-pituitarygut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?" 130 : 304-311, 2006
• 39 McBeth J, "Hypothalamic-pituitary-adrenal stress axis function and the relationship with chronic widespread pain and its antecedents" 7 : R992-R1000, 2005
• 40 Pariante CM, "Glucocorticoid receptors in major depression:relevance to pathophysiology and treatment" 49 : 391-404, 2001
• 41 Papadopoulos A, "Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (0.5 mg) dexamethasone suppression test" 112 : 289-294, 2009
• 42 Thompson WG, "Functional bowel disorders and functional abdominal pain" 45 (45): II43-II47, 1999
• 43 Oscar Rodríguez-Fandiño, "From Cytokines to Toll-Like Receptors and Beyond - Current Knowledge and Future Research Needs in Irritable Bowel Syndrome" 대한소화기 기능성질환∙운동학회 16 (16): 363-373, 2010
• 44 Riva R, "Fibromyalgia syndrome is associated with hypocortisolism" 17 : 223-233, 2010
• 45 Yehuda R, "Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder" 150 : 83-86, 1993
• 46 Galli U, "Enhanced negative feedback sensitivity of the hypothalamus-pituitary-adrenal axis in chronic myogenous facial pain" 13 : 600-605, 2009
• 47 Bob P, "Dissociative symptoms and neuroendocrine dysregulation in depression" 14 : CR499-CR504, 2008
• 48 American Psychiatric Association, "Diagnostic and statistical manual of mental disorders" APA 1994
• 49 Bob P, "Depression, cortisol and somatoform dissociative symptoms" 29 : 235-239, 2008
• 50 Fava M, "Depression with physical symptoms: treating to remission" 64 (64): 24-28, 2003
• 51 Mutsuura H, "Depression and anxiety correlate differently with salivary free cortisol in the morning in patients with functional somatic syndrome" 34 : 291-298, 2009
• 52 Morrison MF, "Dehydroepiandrosterone sulfate and psychiatric measures in a frail, elderly residential care population" 47 : 144-150, 2000
• 53 Kudielka BM, "Cortisol in burnout and vital exhaustion: an overview" 28 (28): 34-42, 2006
• 54 Garakani A, "Comorbidity of irritable bowel syndrome in psychiatric patients: a review" 10 : 61-67, 2003
• 55 Claes SJ, "CRH, stress, and major depression: a psychobiological interplay" 69 : 117-150, 2004
• 56 Pruessner JC, "Burnout, perceived stress, and cortisol responses to awakening" 61 : 197-204, 1999
• 57 Mayer EA, "Basic pathophysiologic mechanisms in irritable bowel syndrome" 19 : 212-218, 2001
• 58 Bohmelt AH, "Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls" 67 : 288-294, 2005
• 59 Wiklund IK, "An irritable bowel syndrome-specific symptom questionnaire: development and validation" 38 : 947-954, 2003
• 60 Fries E, "A new view on hypocortisolism" 30 : 1010-1016, 2005